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Abstract 
OBJECTIVE: Increased fetal size is associated with labor dystocia and subsequent need for 
assisted delivery. We sought to investigate if increased fetal adiposity diagnosed 
sonographically was associated with increased risk of operative delivery.  
METHOD: The Genesis Study recruited 2,392 nulliparous patients with a vertex 
presentation in a prospective multicenter study to examine prenatal and intra-partum 
predictors of cesarean delivery. Participants had ultrasound and clinical evaluation performed 
between 39 0/7 and 40 6/7 weeks’ gestation. Data on fetal biometry was not revealed either to 
patients or their managing clinicians. A fetal adiposity composite of fetal thigh adiposity and 
fetal abdominal thickness was compiled for each infant in order to clarify if fetal adiposity 
>90th centile was associated with an increased risk of cesarean or instrumental delivery. 
RESULTS: After exclusions data were available for 2,330 patients. Patients with a fetal 
adiposity composite >90
th
 centile had a higher maternal BMI (24±4 vs. 25±5; p=0.005), 
birthweight (3872 ± 417g vs. 3585 ± 401g; p<0.0001) and rate of induction of labor (47% 
[108/232] vs. 40% [834/2098]; p=0.048) than those patients with an adiposity composite 
d90
th
 centile. Fetuses with adiposity composite >90th centile were more likely to require 
cesarean delivery than fetuses with adiposity <90th centile (p<0.0001). After adjusting for 
birthweight, maternal BMI, and onset of labor, fetal adiposity >90th centile remained a risk 
factor for cesarean delivery (p<0.0001). A fetal adiposity composite >90
th
 centile was found 
to be more predictive of the need for unplanned cesarean delivery than an estimated fetal 
weight >90
th
 centile (OR= 2.20 [95% CI: 1.65 – 2.94; p<0.001] vs. OR=1.74 [1.29 – 2.35, 
This article is protected by copyright. All rights reserved.
p<0.001]. Having a composite adiposity >90th centile was not found to be associated with an 
increased likelihood of operative vaginal delivery when compared with fetuses <90th centile 
(p=0.37).    
CONCLUSION: Fetuses with increased adipose deposition were more likely to require 
cesarean delivery. Given that increased fetal adiposity is a risk factor for cesarean delivery, 
consideration should be given to adding fetal thigh and abdominal wall thickness to fetal 

















The clinical challenges associated with delivery of a macrosomic infant have been 
clearly documented
1,2 
and it is known that macrosomia carries an increased risk to the fetus of 
birth trauma including shoulder dystocia and resultant brachial plexus injury.
3,4
 Macrosomia 
also confers an increased maternal risk, with high rates of operative delivery, anal sphincter 
injury and post-partum hemorrhage.
5-7
 While increased birthweight has been established as a 
potential predictor of difficult or traumatic delivery, the effect of fetal body composition on 
labor outcomes is less clear.  
Much research effort has been focused on the effect of maternal metabolic profile, 
body composition and gestational weight gain on birthweight,
8-10
 and it has been proposed 
that infants of obese mothers may develop an abnormal metabolic profile resulting in 
increased fetal adiposity in utero. This programming can result in both childhood and adult 
obesity as well as a cycling of obesity through generations.
11,12
 Predictors of increased fetal 
birthweight and abnormal body composition are not yet clearly defined and it has, for 
instance, been shown in non-diabetic women that birthweight correlates with maternal fat 
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free mass and is not linked to maternal adiposity as has previously been reported in diabetic 
cohorts.
13,14
      
Randomized trials of maternal diet and lifestyle to decrease birthweight in those most 
at risk of macrosomia have yet to result in significant clinical impact.
15,16
One large 
randomized trial has however shown a reduction in fetal adipose tissue deposition and 
measures of neonatal body composition after maternal dietary and lifestyle interventions.
17,18
  
In view of the potential adverse maternal and neonatal oucomes associated with 
traumatic delivery, and the difficulty in predicting those mothers and infants most at risk of 
traumatic birth, we sought to investigate if sonographic markers of increased fetal adiposity 
were capable of identifying those at increased risk of complications of labor and delivery. 
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Methods 
This is a secondary analysis of a prospective, multi-centre, blinded observational 
study to examine prenatal and intra-partum predictors of unplanned cesarean delivery. The 
GENESIS study
19
 was carried out between October 2012 and June 2015, at each of the seven 
Perinatal Ireland Research Consortium sites (Rotunda Hospital, Dublin; National Maternity 
Hospital, Dublin; Coombe Women and Infants’ University Hospital, Dublin; Galway 
University Hospital, Galway; University Maternity Hospital, Limerick; Cork University 
Maternity Hospital, Cork; Royal Jubilee Hospital, Belfast). Institutional Review Board 
ethical approval was obtained at each participating center prior to patient recruitment taking 
place. During the study period nulliparous women were invited to participate and had 
ultrasound and clinical evaluation performed.  
Inclusion criteria for this study were nulliparous women with a singleton, cephalic 
presentation between 39 and 40+6 weeks’ gestation in an uncomplicated pregnancy at 
enrolment. All participants had a confirmed estimated date of delivery by either first trimester 
ultrasound or a second trimester ultrasound which correlated with their menstrual dates. 
Those excluded from participation in the study were multiparous, multiple pregnancies, 
breech presentation, ruptured membranes (at time of study ultrasound) and pregnancy 
complications such as pre-eclampsia, hypertension (requiring anti-hypertensive medication) , 
fetal growth restriction, obstetric cholestasis and gestational diabetes. Pre-existing medical 
conditions such as cardiac disorders, pre-gestational diabetes, seizure disorder or bleeding 
disorders also lead to exclusion from the study. Finally, women who had an ultrasound 
performed after 34 weeks’ gestation for fetal biometry were also excluded from the study, to 
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obviate the potential influence of late ultrasound-derived fetal size estimates on clinical 
decision-making regarding timing or mode of delivery.  
Written informed consent was sought from all women participating in the study. At 
each site there was a Perinatal Ireland employed research sonographer who performed an 
ultrasound for fetal biometry between 39 and 40+6 weeks’ gestation. Baseline maternal 
characteristics were gathered including such as age, weight, height, body mass index (BMI); 
(all obtained at the first antenatal visit), gestational weight gain assessed at the study visit, 
ethnicity, attendance at prenatal classes, model of antenatal care, presence of written birth 
plan, smoking status and highest level of education achieved. 
Standard fetal biometry was measured including biparietal diameter (BPD), head 
circumference (HC), abdominal circumference (AC), and femur length (FL), yielding a 
calculated estimated fetal weight (EFW) using the Hadlock formula. All sonographers 
performing ultrasounds were given specialist training in obtaining fetal adiposity 
measurements prior to patient recruitment to ensure accuracy and reproducibility of images. 
Sonographic images were periodically reviewed for quality control throughout the project by 
a senior sonographer and obstetrician. A fetal adiposity composite consisting of the sum of 
fetal thigh adiposity and fetal abdominal thickness was compiled for each infant. The fetal 
abdominal adiposity measurement was obtained using a standard transverse image of fetal 
abdomen at the level of the fetal stomach and portal sinus as is used for the measurement of 
abdominal circumference.  A measurement was taken of the subcutaneous tissue including 
the skin on the anterior abdominal wall in millimeters halfway between the edge of the rib 
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and the anterior abdominal wall using magnification. (fig 1). Three measurements were taken 
on each fetus and the average used for fetal abdominal adiposity. 
The fetal thigh adiposity was measured by obtaining an image of the femur length 
used in standard biometry and magnifying it to visualize clearly the borders of the diaphysis 
of the femur and the skin surface. Femur length was measured and the calipers were then 
used to find the midpoint of the femur. From this midpoint the calipers were placed on the 
outer edge of the femur to the outer surface of the fetal skin on the mid thigh. A measurement 
was then taken again from the outer edge of the femur to the inner fat surface, the fetal thigh 
adiposity was calculated by subtracting this from the first measurement (Fig 2). This process 
was repeated three times and a mean measurment calculated to ensure accuracy. 
 
Biometric data from this ultrasound examination were not revealed to study 
participants. Managing clinicians were also blinded from the results of fetal biometry, to 
control for potential bias of suspected fetal macrosomia influencing decisions relating to 
timing and mode of delivery. A biophysical score was performed and documented in the 
participants medical records. Findings of an abnormal biophysical profile (<6/8), a diagnosis 
of small for gestational age or an EFW >5,000 grams were revealed to the study participants 
and managing clinicians, with all such revealed cases being excluded from the study. 
Standard perinatal and obstetric data were collected contemporaneously and included 
gestational age at delivery, onset of labour, use of prostaglandin for pre-induction cervical 
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priming, amniotomy, use of oxytocin, maternal fever, type of analgesia used, duration of 
labour, mode of delivery, indication for operative delivery, perineal trauma and blood loss.   
The primary outcome of the study was to investigate if fetal adiposity composite 
>90th centile was associated with an increased risk of unplanned intrapartum cesarean 
delivery. Secondary outcomes included the effects of a fetal adiposity composite >90
th
 centile 
on risk of operative vaginal delivery, fetal outcomes such as Apgar scores <7 at 5 minutes, 
arterial cord pH <7.1, admission to the neonatal intensive care unit, shoulder sytocia and Erbs 





 degree tear.  
Statistical Analysis 
Statistical analysis was performed using the chi‐square test and Fisher's exact test. 
Comparison of means was accomplished with a Student's t-test. Two groups were compared: 
those with a fetal adiposity composite >90
th
 centile and those with a composite d90
th
 centile.  
Multiple logistic regression analysis was used to produce a multivariate model where 
prenatally identifiable characteristics which were significant on simple analysis were 
controlled for maternal body mass index, birthweight and onset of labor. The SPSS software 
package (version 20.0; SPSS, Chicago, IL, USA) was used and a two‐tailed probability 
value of P < 0.05 was considered significant. 
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Results 
The GENESIS study recuited a total of 2,392 study participants. There were 61 
participants excluded for the following reasons; lost to follow up (n=4), diagnosed with 
gestational diabetes (n=5), abnormal biophysical profile (n=33), EFW under 2.5kg or over 
5kg (n= 5), EFW performed after enrolment (n=5) and pre-existing indication for caesarean 
delivery such as breech presentation or medical history (n=9). Therefore a total of 2,331 
patients were included in the final analysis; these represented the cohort of nulliparous 
women who underwent a blinded ultrasound-evaluation of fetal weight after 39 weeks’ 
gestational age and who were deemed suitable for trial of labour at the time of the study 
ultrasound. Data were available for 2,330 of the 2,331 study participants, as one patient had 
incomplete adiposity measurement data. In our study cohort, the mean fetal adiposity was 6.2 
+/- 1.4 (+/- SD). It was normally distributed and the 90th centile was 8.1, used as a cutoff in 
the statistical summaries. Fetal adiposity was ascertained at the study visit (between 39+0 and 
40+6 weeks) and within this narrow time-frame, fetal adiposity was not associated with the 
precise gestation at assessment (correlation=0.1). 
Patients with a fetal adiposity composite >90
th
 centile had a higher maternal BMI 
(25±5 vs. 24±4; p=0.005), birthweight (3872 ± 417g vs. 3585 ± 401g; p<0.0001) and rate of 
induction of labor (47% [108/232] vs. 40% [834/2098]; p=0.048) than those patients with an 
adiposity composite d90
th
 centile. Patients with an adiposity index >90
th
 centile were also 
more likely to have an infant >4000g and >4500g (p<0.0001). Those with an adiposity 
composite >90
th
 centile were more likely to require oxytocin augmentation in labor (60% 
[140/232] vs. 49% [1038/2098]; p=0.002) and to have a second stage of labor longer than 
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three hours in duration (8% [19/232] vs. 4% [86/2098]; p=0.005). Patients with an adiposity 
index >90
th
 centile were also more likely to have an intrapartum pyrexia (6% [15/232] vs. 3% 
[71/2098]; p=0.019). There was no difference in other metrics between both groups. Patient 
demographics and intrapartum characteristics can be seen in Tables 1 and 2. 
Fetuses with an adiposity composite >90th centile were more likely to require 
cesarean delivery than fetuses with adiposity d90th centile (35% vs. 20% p<0.0001). After 
adjusting for birthweight, maternal BMI, and onset of labor, fetal adiposity >90th centile 
remained a risk factor for cesarean delivery (p<0.0001). Those with an adiposity composite 
>90
th
 centile were hence less likely to have a spontaneous vaginal delivery (p<0.0001); this 
remained significant after adjusting for BMI, birthweight and onset of labor (p=0.009). 
Having a composite adiposity >90th centile was not found to be associated with an increased 
likelihood of operative vaginal delivery when compared with fetuses d90th centile (p=0.374); 
this remained the case after adjusting for significant characteristics (p=0.35). Differences in 
modes of delivery among both groups can be seen in Table 3.  
A fetal adiposity composite >90
th
 centile was found to be more predictive of the need 
for unplanned cesarean delivery than an estimated fetal weight >90
th
 centile (OR= 2.20 [95% 
CI: 1.65 – 2.94; p<0.001] vs. OR=1.74 [1.29 – 2.35, p<0.001].  
Maternal and fetal outcomes and markers of morbidity can be seen in Table 4. There 
was no difference in any maternal or fetal outcome seen between those with a fetal adiposity 
composite > or d 90
th
 centile.  
 
This article is protected by copyright. All rights reserved.
Discussion 
In a large prospective cohort of nulliparous pregnancies, fetuses with increased 
adipose deposition were more likely to require cesarean delivery, and to show signs of 
obstructed labor such as intrapartum pyrexia, need for oxytocin augmentation, longer labors 
and a second stage of labor longer than three hours in duration. Those with a fetal adiposity 
composite >90
th
 centile were however not more likely to require operative vaginal delivery 
and there was no increase in the rate of fetal or maternal morbidity compared with those with 
an adiposity composite d 90
th
 centile. The effects of fetal adiposity on mode of delivery 
remained apparent on multiple logistic regression which controlled for prenatally identifiable 
characteristics which were different in cases with a fetal adiposity composite >90
th
 centile; 
namely maternal BMI, birthweight and onset of labor. When compared with traditional fetal 
biometry and estimated fetal weight, increased fetal adipose deposition was also found to be a 
better prenatal predictor of the need for unplanned cesarean delivery.  
 Ultrasound-based measurement of fetal adiposity in the third trimester has been 
shown to be a predictor of both birthweight and newborn percentage body fat.
20-22
 Varying 
methods of assessing adiposity have been investigated including fetal thigh and arm volume 
and fetal abdominal wall adiposity as well as using 2D and 3D ultrasound.
23,24
 While an 
association between ultrasound measured fetal adiposity and neonatal body composition has 
been well investigated, the effect of increased fetal adiposity on mode of delivery and 
maternal and fetal outcomes in labor is less clear. Infants with increased adipose deposition 
may encounter intrapartum complications outside of those that are seen in those infants who 
simply have an above average birthweight. This argument is substantiated when it is 
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considered that those with an adiposity composite >90
th
 centile in our study population were 
more likely to require cesarean delivery even once birthweight was controlled for on multiple 
logistic regression. These findings suggest that measurement of markers of fetal adiposity 
may be worthy of including as part of routine biometry for those having sonographic 
assessment in the third trimester.      
This study has a number of strengths including its prospective, multi-center design 
and the blinding of both patients and clinicians’ to findings of the study. Our study population 
was also largely homogenous and uncomplicated and those with gestational diabetes were 
excluded from our study cohort. Our statistical analysis whereby we controlled for maternal 
BMI, birthweight and onset of labor also adds weight to the argument that increased fetal 
adipose tissue deposition makes it more likely that these infants will require cesarean 
delivery. Our study is not without weaknesses and we would have liked to have access to 
neonatal adiposity measurements to correlate sonographic findings with those found 
clinically after delivery. Also our study was not powered to accurately reflect differences in 
more rare clinical outcomes such as shoulder dystocia and resultant Erb’s palsy at vaginal 
delivery. These are morbidities, which infants with increased adipose deposition may be at 
risk of suffering, however given their infrequent occurrence appreciating a significant 
difference would require a much larger cohort. The measurement of adiposity is also not a 
routine sonographic procedure and as a result could be difficult to reproduce accurately, to 
overcome this training to all sonographers was provided by a senior clinician and images 
were reviewed regularly, also a stepwise approach to measuring adiposity were taken, and is 
described above. This was followed in every sonographic assessment carried out during the 
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study. We also did not explore the role of maternal factors and techniques such as 
sonographic pelvimetry in the need for cesarean delivery in our patient cohort. Some recent 
studies have suggested a role for pelvimetry, measured using CT or MRI, for the 
identification of those at high risk of cephalopelvic disproportion.
25,26
 Combining maternal 
sonographic pelvimetry with fetal adiposity in an effort to assess risk of for unplanned 
intrapartum cesarean could form the basis of future work.    
In conclusion our study found that fetuses with increased adipose deposition were 
more likely to require cesarean delivery; this remained the case after controlling for 
prenatally identifiable risk factors. Increased fetal adiposity was more predictive of the need 
for unplanned cesarean delivery than estimated fetal weight and this raises the potential for 
consideration to adding fetal thigh and abdominal wall thickness to standard sonographic 
fetal assessment in late pregnancy. This additional information may be useful in carrying out 
individualized risk assessments of unplanned cesarean delivery when patients and their care 
providers are making decisions regarding mode of delivery.  
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Figure legends 
Figure 1 shows the sonographic measurement of abdominal adiposity 
Figure 2 shows the sonographic measurement of thigh adiposity
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Maternal Age (years) 29 ± 5 29 ± 5 0.170 
Height (cm) 165 ± 6 165 ± 7 0.779 
BMI (kg/m
2
) 24 ± 4 25 ± 5 0.005 
Gestational Weight Gain (kg) 13 ± 5 14 ± 6 0.061 
Caucasian Ethnicity 1995 (95%) 225 (97%) 0.279 
Prior Smoker 699 (33%) 70 (30%) 0.300 
Current Smoker 185 (9%) 20 (9%) 0.743 
Tertiary Education 1445 (69%) 151 (65%) 0.212 
Type of care 
Midwife-led 1006 (48%) 119 (51%) 
0.352 
Physician-led 1096 (52%) 114 (49%) 
Prenatal Classes 1523 (73%) 176 (76%) 0.312 
Birth plan 826 (39%) 106 (46%) 0.067 
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Gestation at Delivery (weeks) 40.8 ± 0.7 40.7 ± 0.7 0.83 
Onset of 
labor 
Spontaneous 1264 (60%) 124 (53%) 
0.04 
Induction 834 (40%) 108 (47%) 
IOL 
Method 
Oxytocin 395 (19%) 69 (30%) <0.001 
ARM 377 (18%) 60 (26%) 0.004 
Prostin 592 (28%) 78 (34%) 0.09 
IOL reason 
Fetal total 47 (2%) 7 (3%) 0.75 
- APH 5 (<1%) 0 0.46 
- LGA 8 (<1%) 2 (<1%) 0.29 
- NRCTG 6 (<1%) 1 (<1%) 0.70 
- Reduced FM 17 (<1%) 4 (2%) 0.16 
- SGA 13 (<1%) 0 0.23 
Maternal total 128 (6%) 25 (1%) 0.01 
- Gest hypertension 44 (2%) 10 (4%) 0.03 
- maternal age 7 (<1%) 0 0.38 
- maternal disease 8 (<1%) 1 (<1%) 0.91 
- oligohydramnios 48 (2%) 8 (3%) 0.27 
- Pre - Eclampsia 23 (1%) 7 (3%) 0.01 
Post dates 466 (22%) 56 (24%) 0.51 
Rupture membranes 140 (7%) 17 (7%) 0.67 
Other 33 (2%) 2 (<1%) 0.57 
Duration of Labour (hours) 6.6 ± 4.6 7.5 ± 5.5 0.01 
Duration of 1
st
 stage labour > 12 hrs 145 (7%) 15 (6%) 0.79 
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Duration of 2
nd
 stage labour > 3 hrs 86 (4%) 19 (8%) 0.005 
Total duration of Labour > 12 hrs 236 (12%) 43 (19%) 0.001 
Oxytocin augmentation 1038 (49%) 140 (60%) 0.002 
Epidural 1432 (68%) 162 (70%) 0.66 
Meconium stained liquor 480 (23%) 59 (25%) 0.37 
Intrapartum pyrexia 71 (3%) 15 (6%) 0.02 
Birthweight (g) 3585 ± 401 3872 ± 417 <0.0001 
Birthweight < 2500g 5 (<1%) 0 0.46 
Birthweight > 4000g 296 (14%) 84 (36%) <0.0001 
Birthweight > 4500g 31 (1%) 15 (6%) <0.0001 
 
Overlap between IOL methods, not mutually exclusive. 
 
ARM = Artificial Rupture of Membranes 
APH = Antepartum Hemorrhage 
LGA = Large for Gestational Age 
NRCTG = Non-reassuring Cardiotocograph 
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Table 3. Mode of Delivery 
 

















































































Multiple linear/logistic regression analyses: Outcomes adjusted for Maternal BMI, 
birthweight and induction of labor. 
2
Overlap in indications for delivery, not mutually exclusive. 
3
NA (not available) due to insufficient number of events. 
 
APH = Antepartum Hemorrhage 
FBS = Fetal Blood Sample 
UpCS = Unplanned Cesarean Section 
NRCTG = Non-reassuring Cardiotocograph 







































Table 4. Maternal & Fetal Outcomes 
 
 
















Apgar < 7 @ 5min 12 (<1%) 1 (<1%) 0.78 0.97 
Cord pH 7.24 ± 0.11 7.24 ± 0.35 0.96 0.69 
Cord pH < 7.1 14 (1%) 1 (<1%) 0.53 0.48 
Shoulder dystocia 22 (1%) 7 (3%) 0.01 0.24 
Erbs palsy 5 (<1%) 1 (<1%) 0.58 0.74 





 degree tear 68 (3%) 8 (3%) 0.87 0.89 
Episiotomy 866 (41%) 87 (38%) 0.26 0.15 
PPH (EBL>500ml) 241 (11%) 38 (16%) 0.03 0.59 
PPH (EBL>1000ml) 52 (2%) 4 (2%) 0.47 0.09 
Blood transfusion 393 (19%) 64 (27%) 0.001 0.08 
 
*overlap in indications for delivery, not mutually exclusive. 
 
# Multiple linear/logistic regression analyses: Outcomes adjusted for BMI, birthweight and 
induction of labor.  
 
This article is protected by copyright. All rights reserved.
NICU = Neonatal Intensive Care Unit 
PPH = Postpartum Hemorrhage 
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